<DOC>
	<DOCNO>NCT01371734</DOCNO>
	<brief_summary>This double-blind study evaluate Desvenlafaxine Succinate Sustained-Release ( DVS SR ) versus placebo Treatment Children Adolescent Outpatients Major Depressive Disorder ( MDD ) .</brief_summary>
	<brief_title>A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Desvenlafaxine Succinate</mesh_term>
	<criteria>Age &gt; =7 &lt; 18 year age Primary diagnosis major depressive disorder ( MDD ) CDRSR score &gt; 40 History suicidal behavior require precaution suicide Not generally healthy medical condition History psychosis bipolar disorder Seizure disorder</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>MDD</keyword>
	<keyword>Depression</keyword>
</DOC>